Insider Selling: Docusign (NASDAQ:DOCU) Insider Sells 1,682 Shares of Stock

Key Points

• Insider Robert Chatwani sold 1,682 shares of DocuSign stock on September 15th at an average price of $80.30, resulting in a total transaction value of $135,064.60.
• Despite the insider selling, DocuSign's stock showed a slight increase of 0.2% on Tuesday, reaching $81.71 during midday trading.
• DocuSign recently beat earnings expectations, reporting $0.92 EPS compared to a consensus estimate of $0.84 and revenue of $800.64 million, reflecting an 8.8% year-over-year increase.

Docusign Inc. (NASDAQ:DOCU - Get Free Report) insider Robert Chatwani sold 1,682 shares of the stock in a transaction that occurred on Monday, September 15th. The stock was sold at an average price of $80.30, for a total value of $135,064.60. Following the completion of the transaction, the insider owned 69,461 shares in the company, valued at $5,577,718.30. This represents a 2.36% decrease in their position. The transaction was disclosed in a legal filing with the SEC, which can be accessed through this hyperlink.

Robert Chatwani also recently made the following trade(s):

• On Thursday, September 11th, Robert Chatwani sold 983 shares of Docusign stock. The shares were sold at an average price of $79.39, for a total value of $78,040.37.
• On Wednesday, June 18th, Robert Chatwani sold 22,875 shares of Docusign stock. The shares were sold at an average price of $74.79, for a total value of $1,710,821.25.

Docusign Stock Up 0.2%

DOCU stock traded up $0.14 during midday trading on Tuesday, hitting $81.71. 2,748,444 shares of the company traded hands, compared to its average volume of 3,157,219. Docusign Inc. has a twelve month low of $55.14 and a twelve month high of $107.86. The business has a 50 day simple moving average of $75.89 and a 200-day simple moving average of $79.23. The stock has a market capitalization of $16.43 billion, a price-to-earnings ratio of 61.79, a price-to-earnings-growth ratio of 4.28 and a beta of 1.02.

Docusign (NASDAQ:DOCU - Get Free Report) last announced its quarterly earnings results on Thursday, September 4th. The company reported $0.92 EPS for the quarter, beating the consensus estimate of $0.84 by $0.08. Docusign had a return on equity of 14.01% and a net margin of 9.08%.The company had revenue of $800.64 million for the quarter, compared to the consensus estimate of $780.35 million. During the same quarter last year, the company posted $0.97 earnings per share. The company's revenue for the quarter was up 8.8% compared to the same quarter last year. Docusign has set its Q3 2026 guidance at EPS. FY 2026 guidance at EPS. Equities research analysts forecast that Docusign Inc. will post 1.17 EPS for the current year.

Docusign announced that its board has authorized a stock repurchase plan on Thursday, June 5th that allows the company to repurchase $1.00 billion in shares. This repurchase authorization allows the company to repurchase up to 6.6% of its shares through open market purchases. Shares repurchase plans are typically a sign that the company's management believes its shares are undervalued.

Hedge Funds Weigh In On Docusign

A number of hedge funds and other institutional investors have recently added to or reduced their stakes in DOCU. State Street Corp lifted its holdings in shares of Docusign by 3.0% during the 2nd quarter. State Street Corp now owns 8,074,976 shares of the company's stock valued at $628,960,000 after purchasing an additional 236,494 shares in the last quarter. American Century Companies Inc. lifted its holdings in shares of Docusign by 1.6% during the 2nd quarter. American Century Companies Inc. now owns 5,564,318 shares of the company's stock valued at $433,405,000 after purchasing an additional 86,560 shares in the last quarter. Geode Capital Management LLC lifted its holdings in shares of Docusign by 1.5% during the 2nd quarter. Geode Capital Management LLC now owns 3,985,808 shares of the company's stock valued at $309,910,000 after purchasing an additional 59,941 shares in the last quarter. UBS AM A Distinct Business Unit of UBS Asset Management Americas LLC lifted its holdings in shares of Docusign by 18.6% during the 1st quarter. UBS AM A Distinct Business Unit of UBS Asset Management Americas LLC now owns 2,028,505 shares of the company's stock valued at $165,120,000 after purchasing an additional 318,698 shares in the last quarter. Finally, Wellington Management Group LLP lifted its holdings in shares of Docusign by 372.5% during the 1st quarter. Wellington Management Group LLP now owns 1,826,949 shares of the company's stock valued at $148,714,000 after purchasing an additional 1,440,269 shares in the last quarter. Institutional investors own 77.64% of the company's stock.

Analysts Set New Price Targets

Several research analysts recently commented on the company. Piper Sandler raised their target price on Docusign from $85.00 to $90.00 and gave the stock a "neutral" rating in a research report on Friday, September 5th. Bank of America raised their target price on Docusign from $85.00 to $102.00 and gave the stock a "neutral" rating in a research report on Friday, September 5th. Royal Bank Of Canada raised their target price on Docusign from $90.00 to $95.00 and gave the stock a "sector perform" rating in a research report on Friday, September 5th. Zacks Research upgraded Docusign from a "hold" rating to a "strong-buy" rating in a research note on Tuesday, September 9th. Finally, Wall Street Zen upgraded Docusign from a "hold" rating to a "buy" rating in a research note on Saturday. One equities research analyst has rated the stock with a Strong Buy rating, four have assigned a Buy rating and fourteen have given a Hold rating to the stock. According to MarketBeat.com, the stock has a consensus rating of "Hold" and an average target price of $94.14.

About Docusign

DocuSign, Inc provides electronic signature solution in the United States and internationally. The company provides e-signature solution that enables sending and signing of agreements on various devices; Contract Lifecycle Management (CLM), which automates workflows across the entire agreement process; Document Generation streamlines the process of generating new, custom agreements; and Gen for Salesforce, which allows sales representatives to automatically generate agreements with a few clicks from within Salesforce.

This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest and most accurate reporting. This story was reviewed by MarketBeat's editorial team prior to publication. Please send any questions or comments about this story to contact@marketbeat.com.